Health Care/Hospital

Advancing Cancer Treatment: Leo Cancer Care and THERYQ Collaborate on Innovative FLASHDEEP Patient Positioning

PEYNIER, France, Oct. 2, 2023 /PRNewswire/ -- The collaboration between Leo Cancer Care and THERYQ brings together the extensive expertise of both organizations to create an integrated solution that promises to revolutionize the treatment of deep-seated tumors. Leveraging cutting-edge technology ...

2023-10-02 20:31 1555

MedAlliance Acquired by Cordis for up to USD 1.135 Billion

GENEVA, Switzerland, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up ...

2023-10-02 20:27 7678

ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision loss

JENA, Deutschland and INGELHEIM, Deutschland, Oct. 2, 2023 /PRNewswire/ -- ZEISS Medical Technology and Boehringer Ingelheim announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vis...

2023-10-02 20:00 1464

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

SHENZHEN, China, Oct. 2, 2023 /PRNewswire/ -- The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinaft...

2023-10-02 16:24 2491

China Review Studio and Chinese Red Cross Foundation Release "Generation Vax" Documentary for Broadcast Internationally

The documentary outlines China's contribution to vaccine science, research, and production since the COVID-19 pandemic and includes a call for science and infectious disease research to be borderless. BEIJING, Oct. 2, 2023 /PRNewswire/ -- China Review Studio, in collaboration with Chinese R...

2023-10-02 15:00 2222

MedAlliance Acquired by Cordis for USD 1.135 Billion

GENEVA, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of$200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up to $775M throu...

2023-10-02 11:44 2332

Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant inHong Kong, the first market in Asia, a calcitonin gene-related peptide (CGRP) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine inHong Kong[3]...

2023-09-29 17:03 2765

#UseHeart movement rallies for change as heart disease continues to claim most lives

GENEVA, Sept. 29, 2023 /PRNewswire/ -- This World Heart Day, the World Heart Federation (WHF) is urging all sectors and citizens to join forces and take down cardiovascular disease (CVD) from its "number one killer" position.

2023-09-29 16:04 2210

Bowtie designed insurance plan for individuals aged 50+ before retirement

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- As individuals in their 50s approach retirement, they not only face the loss of a stable monthly income but also the termination of group medical insurance. Considering the increased risk of illness associated with aging, having adequate coverage becomes ...

2023-09-29 15:40 3333

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety prof...

2023-09-29 12:13 2134

Cutting-edge cancer imaging tool allows doctors to efficiently adapt radiotherapy treatment

First patient treated on radiotherapy system equipped with HyperSight imaging solution at Icon Cancer Centre MELBOURNE, Australia, Sept. 29, 2023 /PRNewswire/ -- An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for pati...

2023-09-29 10:06 1901

Academic Conference on "Research on Female Reproductive Health in International Perspective" Successfully Concluded

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- On September 22nd, the academic conference on "Female Reproductive Health Research in International Perspective", organized by Hong Kong Research Institute of Modern Chinese Medicine for Reproductive Anti-aging(HKMCMRA), was successfully concluded in Hong...

2023-09-29 09:00 2933

Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure

HANGZHOU and SHAOXING, China, Sept. 29, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces positive interim data from the Phase IIb expansion cohort (the "Expansion Cohort") of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) for functional cure of ch...

2023-09-29 08:10 2546

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

82.4% of patients without prior CAR-T achieving Complete Response (CR) or better ROCKVILLE, Md. and SUZHOU, China, Sept. 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-qualit...

2023-09-29 08:00 2646

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titledMethod and System of Monitoring a Diabetes Treatment Plan("Predictive A1c") has been granted in Singapore and has rec...

2023-09-28 20:28 5184

AIA celebrates the grand opening of "AIA Alta Wellness Haven"

Hong Kong insurance industry's first one-stop wellness realm that integrates science andEast-meets-West philosophy Amplifies AIA's High Net Worth Proposition with the establishment of "AIA Club Alta" HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Following the resounding success of the launch of "A...

2023-09-28 17:27 2778

PATIENTS SPEAK UP ABOUT KIDNEY DISEASE

COMMUNITY HEALTH CAMPAIGN "LIVE YOUR WAY" LAUNCHES ACROSS SINGAPORE * Life with kidney disease the focus of new public health campaign * Baxter Healthcare and National Kidney Foundation partner for patients SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Baxter International, a global medtech leade...

2023-09-28 13:48 2018

ScolioLife® Scoliosis & Spine Correction Clinic: A Beacon of Hope for Patients

~ ScolioLife® Pioneers a Comprehensive and Holistic Approach to Scoliosis Management ~ SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Dr Kevin Lau , renowned scoliosis specialist and founder of ScolioLife®, has introduced an innovative and holistic approach...

2023-09-28 12:04 1799

BIOHK2023 LEAVES A MARK ON BIOTECH COMMUNITY: MUST-KNOW HIGHLIGHTS

HONG KONG, Sept. 28, 2023 /PRNewswire/ -- The journey of BIOHK2023 began with an unforgettable opening ceremony on day one, welcoming theNobel Trust Foundation, Dr. Michael Nobel and delivering a noteworthy speech by Mr. Peter Nobel. BIOHK had the privilege of hosting distinguished doctors, profe...

2023-09-28 10:00 2409

Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting

SHANGHAI and HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2023-09-28 08:30 1928
1 ... 96979899100101102 ... 566